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AbstractLipid nanoparticles are getting a growing scientific and technological interest, worldwide. Either Solid Lipid 
Nanoparticles (SLNs), Nanostructured Lipid Carriers (NLCs), Lipid Drug Conjugates (LDCs)  or Polymer-Lipid 
Nanoparticles (PLNs) have been produced and investigated  last years, being reccomended as emerging carrier 
systems for many food and biomedical applications. An overview of the last publications, mainly since 2017 is 
presented, underlying the most important methods and techniques used for their preparation (e.g. high shear homogenization in hot and cold conditions, ultrasound assisted melt emulsification) as well techniques applied for 
measuring the size, calorimetric properties, zeta-potential, etc.  Most relevant data related to the use of food-grade ingredients and designed lipid nanoparticles as delivery systems for organic and inorganic bioactive molecules in 
food or packaging’s are presented. The major reason for this trend in food science is the aim to overcome problems associated with the low bioavailability of many lipophilic bioactive compounds which are claimed to bring 
benefits to human health (carotenoid or anthocyanin pigments, sterols, vitamins). Finally,  the recent applications of  different formulas of lipid nanoparticles as drug carriers for in vitro experiments or for in vivo therapy (oral, 
parenteral or transdermal formulas) are  presented.
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IntroductionSince the beginning of the 1990s the lipid na-
noparticles are getting a growing scientific and 
technological interest, worldwide. Nowadays Solid 
Lipid Nanoparticles (SLNs), Nanostructured Lipid 
Carriers (NLCs) and Lipid Drug Conjugates (LDCs) have been already produced and investigated as carrier systems for many applications. Lipid na-noparticles were developed as an alternative to 
former carriers, such as  polymeric nanoparticles, 
self-emulsifying delivery systems, liposomes,  mi-
cellar solutions microemulsions, are still exploited 
as carriers for bioactives’ delivery (Rawat, 2011, 
Socaciu, 2019). Recently it was reviewed an over-view of different preparation methods of polymer-
ic and novel lipid-based (niosome and solid lipid) 
nanoparticles (Ghasem, 2018).
Solid Lipid Nanoparticles (SLNs) are  typi-cally spherical  structures with an average di-
ameter between 10 and 1000 nm,  possesses a solid lipid core matrix that can solubilize lipo-philic molecules and is stabilized by a surfactant 
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(Fig.1). The core lipids can contain triglycerides, 
fatty acids,  waxes and mixtures of these mol-ecules. The lipid core is stabilized by surfactants 
(emulsifiers), e.g. diglycerides or  monoglycerides, 
short chain fatty acids, sterols (cholesterol), phos-
pholipids, sphingomyelins, bile salts (sodium tau-
rocholate) (Mehnert, 2001; Singh,  2018).The development of new formulas for SLNs is 
one of the emerging fields of lipid nanotechnology 
with several potential applications in food, 
cosmetic or pharmaceutical research, drug delivery or clinical medicine. Due to their size-dependent 
properties, lipid nanoparticles offer the possibility to develop new prototypes or therapeutics with increased bioavailability along with controlled and 
site specific drug delivery. SLNs are well tolerated 
in vivo due to their composition containing 
physiological, similar lipids (Mashaghi, 2013).NLCs were primarily considered for the delivery of lipophilic drugs but their suitability for hydrophilic drugs is also well established. The biocompatible nature of lipids is responsible for 
NLC development as a promising drug delivery, having superior characteristics over other lipid 
formulations (Salvi, 2019).
Nanostructured Lipid Carriers (NLCs) 
are modified SLNs with improved loading 
capacity, drug stability and preventing the drug 
leakage. Fig.1. represents the structure of SLN in 
comparison with NLC, as well the delivery ways. 
The NLCs include a blend of solid and liquid lipids which results in a partially crystallized lipid system and imparts many advantages over 
SLNs such as enhanced drug loading capacity, 
drug release modulation flexibility and improved stability. NLC have found numerous applications in both pharmaceutical and cosmetic industry due to 
their easier preparation, the feasibility of scale-up, 
biocompatibility, non-toxicity, enhanced targeting 
efficiency and the possibility of site-specific delivery via various routes of administration 
(Qianwen, 2017).
The lipid-drug conjugates (LDCs) have the therapeutic actives chemically bound to a lipid 
Figure	1. Comparative  structure and properties of the lipid nanoparticles SLN vs. NLC
(from Patel, 2013)
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moiety like fatty acids or phospholipids, fabrica-ted in nano-size and can be prepared in order to 
increase the drug loading and hence prevent leak-age of a highly polar drug from a lipophilic matrix. 
Recently, it was reviewed  the preparation of lipid 
drug conjugates, processed as nanoparticles, their 
characterization and different applications, as  a 
suitable drug delivery approach (Piya, 2017).Polymer-based nanoparticles are also im-portant components for drug delivery. These na-noparticles can effectively direct drug delivery 
to specific targets and improve drug stability and controlled drug release. Polymer-Lipid Na-
noparticles (PLNs), represent a new type of car-
rier that combines liposomes and polymers, have been employed in recent years. These nanopar-ticles possess the complementary advantages of polymer nanoparticles and liposomes. PLNs have 
core-shell structures, the polymer core providing 
a stable structure, while the phospholipid shell of-fers good biocompatibility. The two components 
increase the drug encapsulation efficiency rate, 
facilitate surface modification, and prevent leak-
age of water-soluble drugs.  Recently (Qianwen, 
2017), published an overview about the current state of development for the polymer nanoparti-
cles, NLCs’ and PLNs’ including many useful infor-mations about  such drug delivery systems. 
Recently, there were reviewed new data about 
NLCs, focused on their structure, the various 
fabrication techniques  and the characterization 
techniques which are critical in the development of a suitable and stable formulation. The same review also provides an insight into the potential 
of NLC as site-specific delivery systems and the therapeutic applications explored via various 
routes of administration (Archana, 2018).
Methods	of	preparation
Recently, there were reviewed the main 
methods of preparation for SLNs/NLCs, the 
recommended excipients, their characterization 
and significant findings related to their stability and 
oral administration (Ganesan and Narayanasamy, 
2017).  Initially used for the production of solid lipid 
nanoemulsions, the method applied to obtain SLNs 
is named generically “High shear homogenization” 
(HSH) and involve high pressure homogenization 
which pushes the liquid (hot lipid mixture) with 
high pressure (100-2000 bar) through a narrow 
gap ranging a few microns. The fluid accelerates 
to a very short distance at very high viscosity, this high shear stress and cavitation forces disrupt the particles down to submicron range. As low as 5% to as high as of 40% lipid content has been 
Figure	2. Techniques and steps used to prepare SLNs: hot (a) and cold (b) homogenization
(from Ganesan and Narayanasamy, 2017)
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investigated. Two general approaches to obtain SLNs by HSH are hot homogenization and cold 
homogenization (Mehnert and Mader, 2001). Fig. 
2 presents comparatively the main steps of hot (a) 
and cold (b) homogenization to obtain SLNs.The hot homogenization is generally carried out at temperatures above the melting point of the lipid. A pre-emulsion of the drug loaded lipid 
melt and the aqueous emulsifier phase (same 
temperature) is obtained by high shear mixing 
device. The product is a hot oil/water emulsion, its cooling leading to the crystallization of the lipid and the formation of SLNs. Smaller particle sizes are obtained at higher processing temperatures 
due to lower viscosity of the lipid phase. However, high temperature may increase the degradation rate of the drug and the carrier. Increasing the homogenization temperature or the number of cycles often results in an increase of the particle 
size due to high kinetic energy of the particles. 
Generally, 3-5 homogenization cycles at a pressure 
of 500-1500 bar are used (Mehnert and Mader, 
2001; Jenning et al., 2002).
 The cold homogenization has been deve-lo ped to overcome the temperature-related degra-
dations, loss of drug into the aqueous phase and partitioning associated with hot homogenization method. Unpredictable polymeric transitions of the lipid due to complexity of the crystallization step of the nanoemulsion resulting in several 
modifications and/or super cooled melts. Here, drug is incorporated into melted lipid and the 
lipid melt is cooled rapidly using dry ice or liquid nitrogen. The solid material is ground by a mortar 
mill. The prepared lipid microparticles are then 
dispersed in a cold emulsifier solution at or below the room temperature. The temperature should be regulated effectively to ensure the solid state 
of the lipid during homogenization. However, 
compared to hot homogenization, larger particle sizes and a broader size distribution are typical for 
cold homogenization samples (Ekambaram et al., 
2012).
Recently, the nano spray-drying (NSD) techni-
que was considered as a fast, innovative one-step method to produce SLNs as a dry powder starting from a lipid/leucine oil/water emulsion. 
In a specific application, Compritol was chosen as wall-forming lipid and Rapamycin as a model drug to be loaded into SLNs and Lutrol F68 as surfactant using the high-shear homogenization method. A yield of 51% was achieved to obtain a 
SLNs population of a size around 150nm (Glaubitt, 
2019).
Another method, named Supercritical Assis-
ted Injection in a Liquid Antisolvent (SAILA) was also proposed for the production of SLNs 
containing soy lecithin, cholesterol, stearic acid and acetone or ethanol as solvents. SLNs with mean dimensions of 158 - 326 nm were 
obtained for soy lecithin particles, 151 - 207 nm for cholesterol and 364 - 462 nm for stearic acid particles. All the suspensions were stable over 30 
days of observation (Trucillo, 2019).
Melt-Emulsification combined with Ultrasoni-
ca tion Method  was recently reported (Sreedhar et 
al., 2019). Fig. 3 presents the most important steps to obtain NLCs by using this method.
MUNTEAN et al.
Figure	3. Melt-Emulsification & Ultrasonication Method to obtain NLCs (Sreedhar et al., 2019)
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High-pressure homogenization was success-fully applied to prepare NLCs which incorporate 
Nimodipine. Their morphology (spherical shape 
of 70 nm with a smooth surface) was observed by a transmission electron microscope and the 
powder by X-ray diffraction, differential scanning 
calorimetry, and Fourier transform infrared spec-
troscopy, respectively. The preparation had a high 
efficiency of 86.8%, the relative bioavailability of Nimodipine -loaded NLCs being 160.96% rela-
tive to free Nimodipine suspensions, providing a promising nanoplatform for hydrophobic drug de-
livery (Teng, 2019).
Charcosset et al. (2005) presented another process for the preparation of SLN using membrane 
contactor. Shortly, the lipid phase was melted and 
pressed through ceramic membrane pores (0.1-
0.45 microns) and SLNs were formed by cooling to room temperature. 
Recently, Gao and McClements (2016) applied the the phase inversion temperature method to produce SLNs using a Surfactant/oil/water 
system (Brij 30, C12E4)/oil (octadecane)/water, maintained at a temperature above the phase 
inversion, and followed by cooling below the lipid nanoparticle crystallization point. 
The detailed knowledge of the structure of the 
lipid nanoparticles was highlighted recently, as 
well the design of these nanocarriers, proposing 
solutions for their formulation (Gordillo-Galeano, 
2018).
Evaluation	of	physico-chemical	properties
The successful applications of SLNs, NLCs or 
PLNs are related to their stability, physicochemical 
properties, mainly determined by the components 
(e.g. lipids, emulsifiers) and their compatibility, by excipients and the preparation methods. Table 1 include the main methods used to characterize the structure of SLNs and NLCs 
(Ganesan, 2017). 
Recently, Talele (2018) prepared biocompatible SLNs with glycerol monostearate as lipid and varying combinations of sodium deoxycholate 
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Table	1. Modern methods and techniques used to determine different physico-chemical properties of lipid nanostructured particles.
Physico-Chemical properties Methods/Techniques
Shape and surface morphology Transmission electron microscopy (TEM)Scanning electron microscopy (SEM)
Phase contrast optical microscopy (PCM)
Atomic force microscopy (AFM)Freeze fracture microscopy
Size and size distribution Dynamic light scattering (DLS)Electron microscopy (SEM/TEM)Optical microscopy
Photon correlation spectroscopy (PCS)Electrical surface potential and and electrophoretic mobility Zeta potential measurementLaser light scattering techniqueCalorimetric properties Differential Scanning Calorimetry (DSC)
Surface hydrophobicity Hydrophobic interaction chromatographyTwo-phase partitionContact angle measurement
X-ray photoelectron spectroscopy
Synchrotron radiation X-ray (SAX)Density Gas pycnometryMolecular weight Gel permeation chromatography (GPC)Rheology ViscosimetryRelease In vitro Dialysis membrane dissolution test
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and cholate (bile salts to lipid ratio 8% w/w) as 
emulsifiers. The detailed characterization was 
performed using a combination of light scattering, 
microscopic, calorimetric, and spectroscopic 
techniques. It was seen that different compositions of bile salts yield nanoparticles with different 
sizes (from 487 to 652 nm), depending on the deoxycholate per cholate ratios.  
Differential scanning calorimetry (DSC) 
has emerged as a helpful technique both to characterize SLNs obtained by phase inversion 
temperature, their capability as drug delivery systems and interactions with bio-membranes DSC Studies were applied also on (Montenegro et 
al., 2011; Gao and McClements, 2016; Montenegro, 
2018).
When compared idebenone (IDE)-loaded SLN interactions with bio-membranes assessed by DSC using in vitro interactions with multi-
lamellar liposomes as a model of bio-membrane, 
the results suggests the possibility of qualitatively predicting in vitro IDE skin penetration from IDE-loaded SLN utilizing the calorimetric parameters obtained from interaction experiments between the carriers under investigation and a model of bio-membrane. Suspensions of SLNs 
stabilized with emulsifiers have been extensively 
investigated since 3 decades as drug carriers, although details of their ultrastructure are poorly 
defined. Previously, a novel microwave-assisted 
microemulsion-based technique to prepare SLNs was reported. To understand the detailed internal 
structure of these SLNs, ultra-small angle neutron 
scattering (USANS) and small angle neutron 
scattering (SANS) experiments were conducted on suspensions of hydrogenated stearic acid SLNs stabilized with hydrogenated Tween 20 surfactant in D2O (Shah, 2019).
Applications	in	food	science	
Nowadays, in food science and technology, edible coatings incorporated with nanostructures 
as systems of controlled release of flavors, colorants 
and/or antioxidants and antimicrobial substances, are used for thermal and environmental protection of active compounds. Such functionalized 
nanostructures have the benefit of incorporating natural substances obtained from the food 
industry that are rich in polyphenols, dietary 
fibers and antimicrobial substances. In addition, 
the polymers employed on its preparation, such 
as polysaccharides, solid lipids and proteins that are low cost and developed through sustainable 
processes, are friendly to the environment. 
Recently, a review was dedicated to the description of materials commonly used in the preparation 
of these nanostructures, the main ingredients used for functionalization and preparation of 
edible coatings, as well as the advances that these structures have represented when used as 
controlled release systems, increasing the shelf life and promoting the development of new products that meet the characteristics of functionality for 
fresh foods ready to eat (Gonzalez-Reza, 2018).Notable progress has been achieved in the preparation of nanoformulas containing selected 
dietary polyphenols (from crude extracts or 
standardized fractions) (Antal , 2017) or beta-carotene-loaded NLCs stable over time and offer a sustainable system for new functional 
foods (Pezeshki, 2019). 
In another study, the formation of lipid 
nanoparticles (570-780 nm)  with low (corn 
and olive oil) or high temperature melting lipids 
(cocoa butter and hydrogenated coconut oil) 
stabilized with Tween 80 was achieved. This work demonstrated the potential of lipid nanoparticles to protect lipophilic bioactive compounds with 
a high digestibility and bioaccessibility (Salvia-
Trujillo, 2019).A SLN nanoparticulate delivery system was prepared for developing a food grade carrier for 
(-)- epigallocatechingallate (EGCG), the major constituent in green tea. EGCG-SLNs were produced 
by the hot homogenization method, had an average 
particle size of 108-122 nm, with an encapsulation 
efficiency up to 68.5%. Such food grade SLNs protected successfully EGCG along the storage period as well as under the adverse conditions 
at neutral pH values. (Shtay, 2019). Chitosan, an excipient having positive characteristics such as muco-adhesiveness and ability to open epithelial-tight-junctions was functionalized with lipophilic 
stearoyl groups and dopped with curcumin, as a model drug.  This nanocomplex was characterized and tested in vitro. The curcumin entrapment in the complex prolonged the permanence of drug in 
the systemic circulation, as compared to curcumin 
solution (Chirio,2018). The results of another 
study shows the efficacy of curcumin-loaded NLCs 
in the treatment of CNS diseases. (Malvajerd, 
2019).
MUNTEAN et al.
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Nanoencapsulation of α-tocopherol (α-TOC) by blending sodium oleate and rebaudioside A was successfully prepared by self-assembly method 
under mild conditions, the loading capacity 
of α-TOC was 30 wt% of sodium oleate. The freeze-dried complex had great stability under ambient conditions and is generally recognized 
as safe (GRAS) ingredient with great potential to 
supplement α--TOC in food as well in cosmetic 
products (He, 2018).The development of engineered nano-sized 
materials (ENM) produced with food-grade ingredients and designed as delivery systems for organic and inorganic materials has gained increasing interest. The major reason for this trend is the aim to overcome problems associated with the low bioavailability of many bioactive 
compounds (BC) which are usually claimed to 
benefit human health. In this review, outcomes of studies investigating the potential bioavailability enhancement of BC using ENM as delivery systems are summarised and discussed. It focuses on in 
vitro and in vivo studies carried out with ENM produced with food-grade materials and designed 
for the delivery of vitamins, other secondary 
plant metabolites and minerals. Furthermore, the physical and physicochemical aspects governing 
the preparation of the systems, the loading of the 
BC, the stability of the delivery systems in food 
applications and finally the release of the BC in the gastrointestinal tract are also considered. The mechanisms leading to an enhanced 
bioavailability are based on (i) improved solubility 
of the BC under gastrointestinal conditions, 
(ii) the protection of the BC from the chemical 
conditions in the gastrointestinal tract (GIT), 
(iii) the controlled release within the GIT or (iv) an improved transfer through the intestinal wall. The main outcome of the review is that particle 
size, surface properties and physical state of the 
ENM are key parameters to be controlled aiming at an enhanced nutritional value of food materials. 
Furthermore, the bioavailability classification 
scheme (BCS) can help to understand the efficacy 
of different ENM for the delivery of specific BC 
(Oehlke, 2014).
Applications	in	biomedical	sciences	Nanosciences offers an operative tool in terms of using environmental friendly nanomaterials 
with increased stability, good carrier properties, 
high bioavailability, targeting, and controlled release  of natural bioactives or synthetic drugs while protecting active constituents against physico-chemical alterations. The interest of the 
scientific community in the field of nanosized delivery of bioactive compounds is demonstrated by the exponential growth of the publications in 
this field the last two decades, SLNs and NLCs being increasigly used as drug delivery systems. There 
are many underexplored capacities of this field with relevance for the biomedical/pharmaceutical 
market. A recent review reveals the methods of 
preparation, characterization and application of several nanoparticles drug delivery system 
(Sharma, 2018) for clinical applications (Huiling, 
2018). Recently a review summarized the 
therapeutic potential of SLNs and NLCs, considering researches and patents on their administration via different routes and their preparations in the 
pharmaceutical market (Uner, 2017).
SLNs have recently acknowledged as a novel sysems to oral and parenteral drug delivery. They combine the advantages of lipid emulsions 
and a polymeric nanoparticles, improving the temporal and in vivo stability comparative to the conventional drug delivery approaches 
(Mehnert et al., 2001). SLNs combine numerous advantages over the other colloidal carriers i.e. 
incorporation of lipophilic and hydrophilic drugs, 
in non-toxic carrier, avoidance of organic solvents 
in their preparation, possibility of controlled 
drug release and drug targeting, increased drug stability and no problems with respect to large scale production. A recent study has demonstrated the use of SLNs as a platform for oral delivery of the mineral 
iron, by incorporating the hydrophilic molecule 
ferrous sulphate (FeSO4) in a lipid matrix contain-
ing stearic acid (Zariwala, 2013). The use of SLNs 
doped with drugs  is developing, using different 
administration routes, including oral, parenter-
al, transdermal, ocular, nasal, respiratory ways 
(Uner, 2017).  Their preparation avoids organic 
solvents, protect sensitive drug molecules from 
the outer environment (water, light) and offer controlled release characteristics and high  bio-
avaiability (Seyfoddin, 2010). SLNs are especially useful in ocular drug delivery as they can enhance the corneal absorption of drugs and improve the ocular bioavailability of both hydrophilic and lipo-
Lipid Nanostructured Particles as Emerging Carriers for Targeted Delivery of Bioactive Molecules: Applications in Food
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philic drugs. Another advantage of SLNs is their stability during autoclave sterilization, a necessary step towards formulation of ocular preparations 
(Lide, 2015)The SLNs and NLCs are also of great importance 
in skin cargo delivery and have vast application in current cosmetic formulations with improved the 
physiochemical stability of the skin based cosmetic products. They can be added to current cosmetic 
formulations without any significant problem due to their physical stability and compatibility with 
other ingredients. (Khezri, 2018).Since most of the sunscreen formulations con-
tain chemicals or synthetic molecules, nowadays, researchers are mainly focusing on herbal formu-
lations. Silymarin, as natural flavonoids with ex-cellent antioxidant properties was incorporated 
in SLNs by micro-emulsion method, the glyceryl 
monostearate being used as lipid, and Tween 80 
as an emulsifier. The SLNs were evaluated for drug 
entrapment, particle size and morphology, zeta 
potential, and polydispersity index. The silymarin-SLNs dispersion was formulated into sunscreen 
cream and evaluated for various parameters, such 
as extrudability, viscosity, spreadability, drug con-
tent, in vitro drug release, ex vivo permeation of 
drug, in vitro and in vivo sun protection factor de-
termination, in vivo skin irritation test, and accel-erated stability studies. The results suggested that the sunscreen containing silymarin SLNs exhibited 
better photoprotective action. (Gladyston, 2018).
A recent review presented the benefits and future perspectives of different lipid nanocarriers used in drug delivery the oral route of delivery being considered to be the most favorable route 
with the highest patient compliance (Nabi, 2019). 
Another recent review compiles the basic know how about the phospholipids and the mechanism through which it improves the bioavailability of drugs. The increase in number of recent reports involving the utilization of drug-phospholipid complex to improve oral bioavailability of drugs thus explains how vital the strategy is for a 
successful oral delivery (Kuche, 2019).
Lipid nanoparticles (LNP) have specifically 
come up for dermal, transdermal, mucosal, intramuscular and ocular drug administration 
routes in the last twenty years. However, they need to be processed as semi-solid formulations such as LNP-hydrogel composites to turn into versatile drug delivery systems able to provide precise 
spatial and temporal control of active ingredient release. Recent developments in the formulation of lipid nanoparticle hydrogel composites are 
highlighted, including examples of successful encapsulation and release of lipophilic drugs 
through the skin, the eyes and by intramuscular 
injections. In relation to lipid nanoparticles, a 
specific emphasis has been put on the LNP key 
properties and how they influence their inclusion in the hydrogel. Polymer matrices include synthetic 
polymers such as poly(acrylic acid)-based 
materials, environment responsive (especially 
thermo-sensitive) polymers, and innovative polysaccharide-based hydrogels. The composite 
materials constitute smart, tunable drug delivery 
systems with a wide range of features, suitable 
for dermal, transdermal, and intramuscular 
controlled drug release (Desfrancois, 2018).
In vitro biocompatibility and Photodynamic 
Therapy (PDT) were performed using L929-
fibroblasts cell line and A549 cancer cell line and 
melanoma BF16-F10, respectively. PDT evidenced 
the antitumor efficacy of Oleic Acid 40% (NLC 40) with reduced cancer cell viability demonstrating that the presence of OA in the NLC seems to potentialize this antitumor effect. According to the 
results obtained, the systems developed may be promising for the incorporation of ClA1Pc in the 
treatment of skin cancer by photodynamic therapy 
(Almeida, 2018). Another review discusses the rationale behind the use of nanotechnology-based strategies for rectal drug delivery and provides a critical overview on the various types 
of nanosystems proposed so far (Melo, 2018).In order to reduce enzymatic degradation and thereby improve the stability of SLNs in the 
gastrointestinal tract (GIT), two amphiphilic macromolecular materials of N-stearyl-N-
trimethyl chitosan (STMC) and N-linoleoyl-N-
trimethyl chitosan (LTMC) were fabricated as 
emulsifier to modify SLNs. Both STMC-SLNs and LTMC-SLNs had excellent gastrointestinal stability 
and efficacy (Qiu, 2018).A recent review is investigating Transdermal 
drug delivery (TDDS) applications, physical 
and chemical characteristics of these systems, 
their routes of penetration through the skin, and summarizes recent advances using these systems 
in treating conditions such as alopecia, wound 
healing, psoriasis, and melanoma (Carter, 2019).
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45
 Bulletin UASVM Food Science and Technology 77 (1) / 2020
ConclusionsLast years we assist to a tremendous interest 
for preparing natural, biocompatible and non-toxic 
nanoparticles, containing mixtures of different edible lipids, emulsifiers and bioactive molecules, 
stable, bioavalable and beneficial for human and animal health.  Beside the increasing number of available preparation recipes and technological 
solutions,  the lipid nanostructured particles are investigate for their size and many other physico-chemical properties which confer stability and improved targeted delivery.  Their capability to act 
as drug- or bioactives’ carriers  with biomedical applications was proved in many experiments. Food science and technology will certainly 
more and more benefit of these new systems by creating innovative mixtures able to increase the accessibility and bioavailability of many lipophilic 
molecules to be stabilized and keeping their bioactivity in food matrices.
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